Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Recurrence × Prednisolone × Clear all

Phase

Phase NA 2 Phase 2 2 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma 10 Prostatic Neoplasms 9 Lymphoma, Large B-Cell, Diffuse 7 Leukemia 7 Lymphoma, Non-Hodgkin 6 Lymphoma, Follicular 6 Burkitt Lymphoma 5 Neoplasm Metastasis 3 Lymphoma, Large-Cell, Immunoblastic 3 Hodgkin Disease 3 Dendritic Cell Sarcoma, Interdigitating 3 Multiple Myeloma 2 Urogenital Neoplasms 1 Thymoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neurotoxicity Syndromes 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Myasthenia Gravis 1 Metastatic Castration-resistant Prostate Cancer 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Biphenotypic, Acute 1 Heart Failure 1 Drug-Related Side Effects and Adverse Reactions 1 Down Syndrome 1 Cardiotoxicity 1

Interventions

Dexamethasone 21 Rituximab 13 Paclitaxel 10 Gemcitabine 10 Cisplatin 10 pomalidomide 9 Lenalidomide 9 Carboplatin 8 Bortezomib 8 Cyclophosphamide 7 Drug Therapy 5 Cytarabine 5 selinexor 4 daratumumab 4 carfilzomib 4 Temozolomide 4 Doxorubicin 4 Docetaxel 4 Bevacizumab 4 Aspirin 4 tisagenlecleucel 3 ibrutinib 3 Vincristine 3 Prednisone 3 Cetuximab 3 Calcium Dobesilate 3 galiximab 2 eculizumab 2 durvalumab 2 blinatumomab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05888493 2026-02-20

LEDA

Novartis

Phase 3 Active not recruiting

Lymphoma, Follicular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡